These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 3284342)
1. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin. Calandra G; Lydick E; Carrigan J; Weiss L; Guess H Am J Med; 1988 May; 84(5):911-8. PubMed ID: 3284342 [TBL] [Abstract][Full Text] [Related]
2. Imipenem/cilastatin therapy for serious infections in neonates and infants. Nalin DR; Jacobsen CA Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042 [TBL] [Abstract][Full Text] [Related]
3. Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infections. Solomkin JS; Fant WK; Rivera JO; Alexander JW Am J Med; 1985 Jun; 78(6A):85-91. PubMed ID: 3890538 [TBL] [Abstract][Full Text] [Related]
4. Seizure-like activity associated with imipenem-cilastatin. Tse CS; Hernandez Vera F; Desai DV Drug Intell Clin Pharm; 1987; 21(7-8):659-60. PubMed ID: 3608817 [No Abstract] [Full Text] [Related]
5. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial. Calandra GB; Hesney M; Brown KR Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of high-dose treatment with imipenem-cilastatin in seriously ill patients. Zajac BA; Fisher MA; Gibson GA; MacGregor RR Antimicrob Agents Chemother; 1985 May; 27(5):745-8. PubMed ID: 3860187 [TBL] [Abstract][Full Text] [Related]
7. Clinical experience with imipenem/cilastatin: analysis of a multicenter study. Shah PM Rev Infect Dis; 1985; 7 Suppl 3():S471-5. PubMed ID: 3901210 [TBL] [Abstract][Full Text] [Related]
8. Imipenem/cilastatin for pediatric infections in hospitalized patients. Nalin DR; Hart CB; Shih WJ; Aziz MA Scand J Infect Dis Suppl; 1987; 52():56-64. PubMed ID: 3331043 [TBL] [Abstract][Full Text] [Related]
9. Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients. Mortimer J; Miller S; Black D; Kwok K; Kirby WM Am J Med; 1988 Jul; 85(1A):17-20. PubMed ID: 3400679 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience. Wang C; Calandra GB; Aziz MA; Brown KR Rev Infect Dis; 1985; 7 Suppl 3():S528-36. PubMed ID: 3901217 [TBL] [Abstract][Full Text] [Related]
11. Prospective randomized comparison of imipenem/cilastatin and cefotaxime for treatment of lung, soft tissue, and renal infections. Diaz-Mitoma F; Harding GK; Louie TJ; Thomson M; James M; Ronald AR Rev Infect Dis; 1985; 7 Suppl 3():S452-7. PubMed ID: 3901207 [TBL] [Abstract][Full Text] [Related]
12. Imipenem-cilastatin in the treatment of respiratory infections in patients with chronic airways obstruction. Wathen CG; Carbarns NJ; Jones PA; Millar A; Croughan MJ; Calder MA; Douglas NJ J Antimicrob Chemother; 1988 Jan; 21(1):107-12. PubMed ID: 3356618 [TBL] [Abstract][Full Text] [Related]
13. The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials. Calandra GB; Ricci FM; Wang C; Brown KR J Clin Pharmacol; 1988 Feb; 28(2):120-7. PubMed ID: 3283176 [TBL] [Abstract][Full Text] [Related]
14. Imipenem/cilastatin: general experience in a community hospital. Iannini PB; Kunkel MJ; Hilton E; Iannini GM Am J Med; 1985 Jun; 78(6A):122-6. PubMed ID: 3859211 [TBL] [Abstract][Full Text] [Related]
15. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections. Keller CA; Villavicencio J; Ramirez C Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287 [TBL] [Abstract][Full Text] [Related]